Safety in iron management
- 30 June 2003
- journal article
- review article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 41, 18-26
- https://doi.org/10.1016/s0272-6386(03)00373-1
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextranKidney International, 2002
- Efficacy and Safety of Iron Sucrose for Iron Deficiency in Patients With Dialysis-Associated Anemia: North American Clinical TrialAmerican Journal of Kidney Diseases, 2001
- European Best Practice Guidelines 9–13 Anaemia managementNephrology Dialysis Transplantation, 2000
- Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trialAmerican Journal of Kidney Diseases, 2000
- Iron and cardiac disease in the end-stage renal disease settingAmerican Journal of Kidney Diseases, 1999
- Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextransAmerican Journal of Kidney Diseases, 1999
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Cardiac function and hematocrit levelAmerican Journal of Kidney Diseases, 1995
- Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic PatientsNephrology Dialysis Transplantation, 1991
- Intravenous iron dextran in clinical medicineJAMA, 1980